Skip to main content
×
×
Home

Maternal lipopolysaccharide alters the newborn oxidative stress and C-reactive protein levels in response to an inflammatory stress

  • Y. Ginsberg (a1), P. Lotan (a1), N. Khatib (a1), N. Awad (a1), S. Errison (a1), Z. Weiner (a1), N. Maravi (a1), M. G. Ross (a2), J. Itskovitz-Eldor (a1) and R. Beloosesky (a1) (a2)...
Abstract

Maternal infection is associated with oxidative stress (OS) and inflammatory responses. We have previously shown that maternal exposure to lipopolysaccharide (LPS) at E18 alters the subsequent offspring immune response. As immune responses are mediated, in part, by OS, we sought to determine if maternal inflammation during pregnancy programs offspring OS and C-reactive protein (CRP) levels. Pregnant Sprague-Dawley rats received intraperitoneal (i.p.) injections of saline or LPS at 18 days’ gestation (n = 4), and pups delivered spontaneously at term. At postnatal day 24, male and female offspring received i.p. injection of LPS. Serum lipid peroxides formation (PD) and CRP levels were determined before and at 4 h following the LPS injection. Pups of LPS-exposed dams had significantly higher basal OS (PD 29.4 ± 5.4 v. 10.1 ± 4.8 nmol/ml) compared with controls. In response to LPS, CRP levels (20.4 ± 2.8 v. 5.7 ± 1.0 ng/ml) were significantly higher among pups of LPS-exposed dams than controls. Prenatal maternal exposure to LPS increases baseline OS levels in neonates and CRP levels in response to LPS. These results suggest that maternal inflammation during the antenatal period may induce long-term sequelae in the offspring that may predispose to adult disease.

Copyright
Corresponding author
*Address for correspondence: Dr R. Beloosesky, Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel. Email tomor2304@yahoo.com
References
Hide All
1. Lazzarotto, T, Lanari, M. Why is cytomegalovirus the most frequent cause of congenital infection? Expert Rev Anti Infect Ther. 2011; 9, 841843.
2. Gajendra, S, Kumar, JV. Oral health and pregnancy: a review. N Y State Dent J. 2004; 70, 4044.
3. Hasegawa, K, Furuichi, Y, Shimotsu, A, et al. . Associations between systemic status, periodontal status, serum cytokine levels, and delivery outcomes in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2003; 74, 17641770.
4. Friese, K. The role of infection in preterm labour. Br J Obstet Gynaecol. 2003; 110(Suppl. 20), 5254.
5. Carta, G, Persia, G, Falciglia, K, Iovenitti, P. Periodontal disease and poor obstetrical outcome. Clin Exp Obstet Gynecol. 2004; 31, 4749.
6. Spinillo, A, Capuzzo, E, Stronati, M, et al. . Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol. 1998; 105, 865871.
7. Blackwell, TS, Christman, JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997; 17, 39.
8. Leitich, H, Bodner-Adler, B, Brunbauer, M, et al. . Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003; 189, 139147.
9. Mednick, SA, Machon, RA, Huttunen, MO, Bonett, D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988; 45, 189192.
10. Ebert, T, Kotler, M. Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J. 2005; 7, 3538.
11. Brown, AS, Derkits, EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010; 167, 261280.
12. Atladottir, HO, Thorsen, P, Ostergaard, L, et al. . Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010; 40, 14231430.
13. Chess, S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr. 1977; 7, 6981.
14. Meyer, U, Murray, PJ, Urwyler, A, et al. . Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry. 2008; 13, 208221.
15. Polivka, BJ, Nickel, JT, Wilkins, JR III. Urinary tract infection during pregnancy: a risk factor for cerebral palsy? J Obstet Gynecol Neonatal Nurs. 1997; 26, 405413.
16. Murphy, DJ, Sellers, S, MacKenzie, IZ, Yudkin, PL, Johnson, AM. Case–control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 1995; 346, 14491454.
17. Yoon, BH, Jun, JK, Romero, R, et al. . Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997; 177, 1926.
18. Beloosesky, R, Weiner, Z, Khativ, N, et al. . Prophylactic maternal N-acetylcysteine before lipopolysaccharide suppresses fetal inflammatory cytokine responses. Am J Obstet Gynecol. 2009; 200, 665, e1-5.
19. Morein, B, Blomqvist, G, Hu, K. Immune responsiveness in the neonatal period. J Comp Pathol. 2007; 137(Suppl. 1), S27S31.
20. Philbin, VJ, Levy, O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res. 2009; 65(5Pt 2), 98R105R.
21. Immunobiology. The Immune System in Health and Disease, 5th edn, 2001. Garland Science: New York, NY.
22. Drake, AJ, Walker, BR, Seckl, JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R34R38.
23. Beloosesky, R, Maravi, N, Weiner, Z, et al. . Maternal lipopolysaccharide-induced inflammation during pregnancy programs impaired offspring innate immune responses. Am J Obstet Gynecol. 2010; 203, 185e1–4.
24. Beloosesky, R, Gayle, DA, Ross, MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. Am J Obstet Gynecol. 2006; 195, 10531057.
25. Awad, N, Khatib, N, Ginsberg, Y, et al. . N-acetyl-cysteine (NAC) attenuates LPS-induced maternal and amniotic fluid oxidative stress and inflammatory responses in the preterm gestation. Am J Obstet Gynecol. 2011; 204, 450e15–20.
26. Aviram, M, Vaya, J. Markers for low-density lipoprotein oxidation. Methods Enzymol. 2001; 335, 244256.
27. el-Saadani, M, Esterbauer, H, el-Sayed, M, et al. . A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989; 30, 627630.
28. Xu, DX, Wang, H, Zhao, L, et al. . Effects of low-dose lipopolysaccharide (LPS) pretreatment on LPS-induced intra-uterine fetal death and preterm labor. Toxicology. 2007; 234, 167175.
29. Chen, YH, Wang, JP, Wang, H, et al. . Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology. 2005; 211, 242252.
30. Ejima, K, Koji, T, Tsuruta, D, et al. . Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system. Biol Reprod. 2000; 62, 178185.
31. Paintlia, MK, Paintlia, AS, Barbosa, E, Singh, I, Singh, AK. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004; 78, 347361.
32. Paintlia, MK, Paintlia, AS, Contreras, MA, Singh, I, Singh, AK. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol. 2008; 210, 560576.
33. Lante, F, Meunier, J, Guiramand, J, et al. . Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain. Free Radic Biol Med. 2007; 42, 12311245.
34. Lante, F, Meunier, J, Guiramand, J, et al. . Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus. 2008; 18, 602609.
35. Fowden, AL, Giussani, DA, Forhead, AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006; 21, 2937.
36. Aviram, M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res. 2000; (Suppl. 33), S85S97.
37. Ross, R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999; 340, 115126.
38. Ridker, PM, Cushman, M, Stampfer, MJ, Tracy, RP, Hennekens, CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998; 97, 425428.
39. Ridker, PM, Glynn, RJ, Hennekens, CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97, 20072011.
40. Kuller, LH, Tracy, RP, Shaten, J, Meilahn, EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case–control study. Multiple risk factor intervention trial. Am J Epidemiol. 1996; 144, 537547.
41. Tracy, RP, Lemaitre, RN, Psaty, BM, et al. . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project. Arterioscler Thromb Vasc Biol. 1997; 17, 11211127.
42. Liuzzo, G, Biasucci, LM, Gallimore, JR, et al. . The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994; 331, 417424.
43. Dempsey, PW, Vaidya, SA, Cheng, G. The art of war: innate and adaptive immune responses. Cell Mol Life Sci. 2003; 60, 26042621.
44. Sun, H, Koike, T, Ichikawa, T, et al. . C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol. 2005; 167, 11391148.
45. Kushner, I, Jiang, SL, Zhang, D, Lozanski, G, Samols, D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann N Y Acad Sci. 1995; 762, 102107.
46. Escobar-Morreale, HF, Luque-Ramirez, M, Gonzalez, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011; 95, 10481058.
47. Wilson, AM, Ryan, MC, Boyle, AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 2006; 106, 291297.
48. Valko, M, Leibfritz, D, Moncol, J, et al. . Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39, 4484.
49. Kushner, I, Rzewnicki, D, Samols, D. What does minor elevation of C-reactive protein signify? Am J Med. 2006; 119, 166e17–28.
50. Kirsten, TB, de Oliveira, BP, de Oliveira, AP, et al. . Single early prenatal lipopolysaccharide exposure prevents subsequent airway inflammation response in an experimental model of asthma. Life Sci. 2011; 89, 1519.
51. Desai, M, Gayle, DA, Casillas, E, Boles, J, Ross, MG. Early undernutrition attenuates the inflammatory response in adult rat offspring. J Matern Fetal Neonatal Med. 2009; 22, 571575.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Developmental Origins of Health and Disease
  • ISSN: 2040-1744
  • EISSN: 2040-1752
  • URL: /core/journals/journal-of-developmental-origins-of-health-and-disease
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed